Igor Matushansky
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
-
- Epigenetics and DNA Methylation 12
- Cancer-related gene regulation 4
- Histone Deacetylase Inhibitors Research 4
-
- Sarcoma Diagnosis and Treatment 13
- Co-authors
- Sara Siddiqi (5 shared papers)Arthur I. Skoultchi (8 shared papers)Carlos Cordon‐Cardo (9 shared papers)Farshid Radparvar (5 shared papers)Joslyn Mills (7 shared papers)Elizabeth Charytonowicz (6 shared papers)Filemon S. Dela Cruz (4 shared papers)Robert G. Maki (8 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Blood (4 papers)Cancer Research (4 papers)Oncogene (2 papers)American Scientist (2 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Igor Matushansky
47 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 83
- Cancer Research 301
- Oncology 524
- Pulmonary and Respiratory Medicine 542
- Molecular Biology 1.1k
- Genetics 144
Countries citing papers authored by Igor Matushansky
This map shows the geographic impact of Igor Matushansky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Matushansky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Matushansky more than expected).
Fields of papers citing papers by Igor Matushansky
This network shows the impact of papers produced by Igor Matushansky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Matushansky. The network helps show where Igor Matushansky may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Matushansky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 229 | |
| 2 | 2007 | 162 | |
| 3 | 2011 | 144 | |
| 4 | 2009 | 122 | |
| 5 | 2012 | 112 | |
| 6 | 2008 | 110 | |
| 7 | 2012 | 99 | |
| 8 | 2003 | 88 | |
| 9 | 2000 | 88 | |
| 10 | 2000 | 76 | |
| 11 | 2012 | 71 | |
| 12 | 2003 | 71 | |
| 13 | 2008 | 66 | |
| 14 | 2012 | 51 | |
| 15 | 2000 | 47 | |
| 16 | 2000 | 45 | |
| 17 | 2000 | 43 | |
| 18 | 2010 | 35 | |
| 19 | Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1. | 2003 | 33 |
| 20 | MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas. | 2011 | 26 |
About Igor Matushansky
Igor Matushansky is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Infectious Diseases, having authored 49 papers that have together received 1.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Epigenetics and DNA Methylation (12 papers), Viral Infections and Outbreaks Research (10 papers), Virus-based gene therapy research (10 papers), Cancer-related Molecular Pathways (7 papers), Vascular Tumors and Angiosarcomas (5 papers), Cancer-related gene regulation (4 papers) and Histone Deacetylase Inhibitors Research (4 papers). The work is most often cited by research in Cancer Research (301 citations), Oncology (524 citations), Pulmonary and Respiratory Medicine (542 citations), Molecular Biology (1.1k citations) and Genetics (144 citations). Igor Matushansky has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Sara Siddiqi, Arthur I. Skoultchi, Carlos Cordon‐Cardo, Farshid Radparvar, Joslyn Mills, Elizabeth Charytonowicz, Filemon S. Dela Cruz, Robert G. Maki, Eva Hernando and Nicholas D. Socci. Their work appears in journals such as Journal of Clinical Oncology, Blood, Cancer Research, Oncogene and American Scientist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.